Composite inflammatory biomarker linked to dementia risk
Jul 21, 2023
Small but significant associations were seen between elevated biomarker levels and worsened cognitive performance.
Distance to neurologist, PCP may explain Alzheimer’s disease disparities
Apr 05, 2024
Non-Hispanic American Indian and/or Alaska Native and Hispanic decedents have to travel further to neurologist than non-Hispanic whites.
Senators ask president for more Alzheimer’s funding
By
Lois A. Bowers
Feb 02, 2018
A group of 14 senators led by Sen. Susan Collins (R-ME), founder and co-chair of the Senate Alzheimer’s Task Force, and Sen. Amy Klobuchar (D-MN) on Wednesday asked President Trump to boost funding...
Donanemab slows clinical progression in early Alzheimer’s disease
Jul 17, 2023
The drug slows clinical progression at 76 weeks for those with low/medium tau and the combined low/medium and high tau pathology population.
5 lessons we’ve learned by not segregating memory care residents
By
Vassar Byrd
Feb 03, 2020
The benefits of not offering memory care in a separate, locked unit far outweigh the effort needed — and we’ve learned some lessons along the way.
Using wearables to track seniors’ sleep-cycle data could protect against frailty, new data shows
By
Aaron Dorman
Nov 20, 2023
By analyzing seniors’ sleep and exercise, data collected from wearables could help demonstrate a risk of frailty, a new study shows.
When it comes to virtual reality, imagination often trumps innovation, research finds
By
Aaron Dorman
Aug 28, 2023
When it comes to virtual reality, programming advances in the tech may not be as important to users as what they bring themselves: their imagination.
Alzheimer’s in danger of straining public funding: report
By
Lois A. Bowers
Oct 05, 2017
Social and demographic trends combined with an expected increase in the incidence of Alzheimer’s diseases due to the growing size of the aging population are in danger of colliding to strain local,...
Medicare may rethink premium hike for pricey Alzheimer’s drug
Jan 10, 2022
The announcement comes shortly after Aduhelm maker Biogen cut the price of the drug by about half, from $56,000 to $28,000 a year.
Brain analyses suggest memory therapy can involve patients’ imagination more than their actual experience
By
Aaron Dorman
Aug 04, 2023
Recent brain research suggests that imagination and recall are just as important as actual experience in reinforcing our memory systems.